Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference12 articles.
1. Murata, Y. Respiratory syncytial virus infection in adults. Curr. Opin. Pulm. Med. 14, 235–240 (2008).
2. Wu, H. et al. Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab. Curr. Top. Microbiol. Immunol. 317, 103–123 (2008).
3. Dall'Acqua, W. F. et al. Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor. J. Biol. Chem. 281, 23514–23524 (2007).
4. Fulginiti, V. A. et al. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 89, 435–448 (1969).
5. Schickli, J. H. et al. Challenges in developing a paediatric RSV vaccine. Hum. Vaccin. 5, 582–591 (2009).
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献